Results patient 5 (Endometrial Atrophy) CONTROL BEFORE INJECTION AFTER INJECTION (6 MONTHS) Incidents and side effects • No serious side effects so far • 2 patients excluded – Poor CD 133+ cell mobilitation – No peripheral venous access 146